Columbia Partners Investment Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Columbia Partners Investment Management’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-91,730	Closed	-$4.54M	–	415
2015 Q2	$4.54M	Sell	91,730 -37,538	-29%	-$2.24M	0.28%	121
2015 Q1	$10.1M	Buy	129,268 +25,549	+25%	+$1.58M	0.54%	72
2014 Q4	$6.29M	Sell	103,719 -66,318	-39%	-$3.33M	0.33%	114
2014 Q3	$7.24M	Sell	170,037 -5,242	-3%	-$281K	0.37%	106
2014 Q2	$10.8M	Buy	175,279 +89,779	+105%	+$5.22M	0.5%	65
2014 Q1	$5.56M	Buy	+85,500	New	+$5.78M	0.24%	136

Other funds holding OREX

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Columbia Partners Investment Management's OREX Position: Q3 2015 in Review

Columbia Partners Investment Management sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2015, closing a stake of 91,730 shares — an estimated $4.54M sold.

Columbia Partners Investment Management first reported a position in OREX in Q1 2014 and held it in 6 quarters. The position peaked at $10.8M in Q2 2014. 132 funds tracked by Wall St. Rank hold OREX as of Q3 2015.

Columbia Partners Investment Management reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
Columbia Partners Investment Management sold 91,730 Orexigen Therapeutics, Inc. shares in Q3 2015, an estimated $4.54M.
Columbia Partners Investment Management first reported a position in Orexigen Therapeutics, Inc. in Q1 2014 and held it in 6 quarters.
Columbia Partners Investment Management's Orexigen Therapeutics, Inc. position peaked at $10.8M in Q2 2014.
132 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2015.

Based on Columbia Partners Investment Management's 13F filing for Q3 2015, filed 10 Nov 2015.